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A simple and effective method was developed for peptide sequencing and protein identifica-
tion through the determination of its N-terminal residue. The method of N-terminal carbam-
idomethylation with iodoacetamide could specifically and remarkably enhance the intensity of
a1 ions in the tandem mass spectra of the peptide derivatives without significantly altering
their fragmentation pattern, thus allowing determination of their N-terminal residues. The
effectiveness and specificity of the method was demonstrated by confirming and extending
sequence interpretation of several model peptides and proteins. The developed method was
then applied in the LC-MS/MS analysis of the tryptic digests of myoglobin and a whole
protein extract from rat heart tissues. The results from database searches were well validated
with the enhancement of a1 ions in tandem mass spectra and the specificity of protein
identification was obtained when the information of N-terminal residues was included in the
database search. (J Am Soc Mass Spectrom 2009, 20, 1214–1223) © 2009 American Society for
Mass SpectrometryProtein identification is a major component ofproteomics, with the methods heavily relying onboth mass spectrometric peptide sequencing and
database searching [1]. Although the application of
tandem mass spectrometry for peptide sequencing
based on the chemistry of peptide fragmentation in the
gas phase has been reported for many years [2–5],
various methodologies are still being developed and
modified for improving the sensitivity and specificity
[6–9]. In common equipment settings, such as tandem
quadrupole, quadrupole-time of flight, and ion trap
mass spectrometers, a, b, and y ions are the most
common peptide fragments observed in low-energy
collisions. Both a and b ions are viewed as N-terminal
fragments, while y ions belong to C-terminal ones.
Theoretically, the sequence of a peptide may be de-
duced from the analysis of fragment ions. However, in
practice, the complete interpretation of product ion
spectra is often hard to achieve without the aid of
database search. Thus, de novo sequencing often ends
up with partial interpretation of some internal se-
quences in peptides. The most common reason is the
absence of b1 ions in product ion spectra of the proton-
ated peptides due to the difficulty to form the corre-
sponding cyclic intermediates [10, 11], which often
posted a challenge for the determination of N-terminal
residues by mass spectrometry.
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doi:10.1016/j.jasms.2009.02.021Several derivatization reagents that were commonly
used to label the N-terminus were found to be able to
promote and stabilize b1 ions and to facilitate the
interpretation process [12–18], some of which focused
on the comparative proteomics by using different iso-
topically labeled reagents. While the reported methods
regarding the derivatization at the peptide N-terminus
could stabilize the modified b1 ions to a certain extent,
none of them seemed to serve as a simple, sensitive tool
to identify the N-terminal residues in proteomics due to
the following reasons. The intensity of many derivat-
ized peptides appeared to be reduced in the analysis
using positive ion mode mass spectrometry compared
with those of underivatized peptides. N-acetylation with
acetic anhydride, phenyl isothiocyanate, or 4-sulfophenyl
isothiocyanate often resulted in a reduced intensity to
some extent. In addition, some derivatization reactions
resulted in different fragmentation patterns in product ion
spectra [14, 18], making it difficult to gain the sequence
information by the comparison of the spectrum of modi-
fied peptide with that of unmodified one. A typical
example was the N-terminal derivatization with phenyl
isothiocyanate, of which the product ion spectrum was
often dominated by b1 and yn-1 ions [14]. However, the
limited amount of fragmentation often resulted in the
limited sequence information. Furthermore, some deriva-
tization regents were not commercially available [17, 18].
While the assignment of b1 ions in MS/MS spectra
has often been used for obtaining information of N-
terminal residues, limited reports on the use of a1 ions
to determine the N-terminus of peptides [19] and pro-
teins [20] have been published. The detection frequency
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ions. The formation of a1 ion was believed to occur via
the fragmentation of b2 ion and/or a2 ion [10]. Because
a1 ion is often intermixed with immonium ions includ-
ing those from the internal residues that are identical to
the N-terminal residue, the determination of the N-
terminal residue is difficult. In this study, a simple and
effective method to specifically and remarkably enhance
a1 ions in the MS/MS spectra of the peptide derivatives
was developed for identifying the N-terminal amino acids
of peptides. Themethod applicability for the enhancement
of a1 ions in mass spectrometric sequencing and protein
identification was demonstrated.
Experimental
Materials and Reagents
Dithiothreitol (DTT), iodoacetamide, ammonium bicar-
bonate, Tris, phenylmethanesulfonyl fluoride (PMSF),
CaCl2, and horse heart myoglobin were purchased from
Sigma-Aldrich (St. Louis, MO). Sequencing grade trypsin
was obtained from Promega (Madison, WI). HPLC grade
formic acid was from Panreac (Barcelona, Spain). HPLC-
grade acetonitrile was obtained from Tedia (Fairfield,
OH). PDAATAAPLR (MW 982.09) was a gift from the
Biology Department, Hong Kong University of Science
and Technology. Octreotide was obtained from GL Bio-
chem (Shanghai) Ltd. Water was purified from a Milli-Q
Ultrapure water system (Millipore, Billerica, MA).
Derivatization of Model Peptides
For the derivatization of PDAATAAPLR, the sample (1
nmol) was dissolved in 10 L 50% ACN, and then
mixed with iodoacetamide (50 L, 55 mM) in ammo-
nium bicarbonate buffer (pH 7.8, 50 mM). The reaction
mixture was allowed to stay at 37 °C in dark place for
60 min. The cyclic octreotide was derivatized under the
same conditions. For the reduction of octreotide, a
mixture of octreotide (1 nmol, 10 L 50% ACN), and
1,4-dithioerythritol (50 l, 10 mM) in ammonium bicar-
bonate buffer (pH 7.8, 50 mM) was kept at 37 °C for 60
min. The reduced octreotide was then derivatized with
the addition of iodoacetamide (50 L, 55 mM in 50 mM
pH 7.8 ammonium bicarbonate buffer) and incubation
for additional 60 min in the dark.
Derivatization of Protein Digests
Myoglobin (5 nmol) were first reduced by 10 mM
1,4-dithioerythritol for 60 min at 56 °C, alkylated with
55 mM iodoacetamide for 60 min in the dark at 37 °C,
and then digested overnight at 37 °C in dark place with
modified trypsin (Promega, sequencing-grade). The re-
action was stopped by addition of formic acid to 5%
final. The resulting tryptic peptides were then subject to
mass spectrometric analysis or stored in 20 °C for
future use.For the preparation of digests of rat heart tissues,
hearts were excised from 4 wk-old male Sprague-
Dawley rats. After washed in PBS-buffered saline, ven-
tricular tissues were immediately frozen in liquid nitro-
gen and ground to a fine powder. The powdered tissues
were homogenized using a Polytron in solubilization
buffer composed of 9.5 M urea, 20 mM Tris (pH 8.0),
and 0.1 mM PMSF. The crude extract was then centri-
fuged at 16,000 g at 10 °C for 1 h. The resultant
supernatant was then reduced by adding DTT to 10 mM
for 60 min, and carbamidomethylated in 50 mM iodoac-
etamide at 37 °C for 60 min in the dark. The reduced
and alkylated sample was then diluted with 4 volumes
of 100 mM ammonium bicarbonate buffer (pH 7.8)
containing 1 mM CaCl2, followed by adding modified
trypsin (Promega, sequencing-grade) at an estimated
enzyme-to-substrate ratio of 1:100 (wt/wt). The mixture
was allowed to stand for over 24 h at 37 °C with
occasional shaking. After incubation, the reaction was
stopped by adding formic acid to 5% final and stored at
20 °C until analysis.
Capillary LC-MS/MS
Capillary LC-MS/MS experiments were conducted on
an ABI QSTAR spectrometer coupled with an Agilent
1100 system with a micro-autosampler. Approximate
200 pmol of each of the model peptides and the tryptic
digest of myoglobin was injected. For the analysis of the
whole protein extract of rat heart tissue, approximate
1.0 mg of digests was used. Samples were injected
directly onto a 0.3 mm  25 cm column packed with
C18 material (LC Packings C18 PepMap 100, 5 m, 100
A; LC Packings, Amsterdam, The Netherlands). Pep-
tides were eluted at a flow rate of 10 L/min with
mobile phase A (99% water, 1% acetonitrile, 0.1% for-
mic acid), to which mobile phase B (99% acetonitrile, 1%
water, 0.1% formic acid) was added by a linear gradient
(initially 1% B for 2 min, and then increased to 40% B at
100 min, to 95% B at 110 min, and then kept isocratic for
10 min).
Mass spectrometric analysis was performed on an
ABI QSTAR spectrometer in information dependent
acquisition mode (IDA) (Analyst QS, Applied Biosys-
tems), selecting the four most intense ions for MS/MS
analysis. A survey scan of 300 to 2000 Da was collected
for 3 s followed by 5 s MS/MS scans of 40 to 1500 Da
using the standard rolling collision energy settings.
Database Searching
In the MS/MS ion search mode, mascot generic files
were generated by using a script embedded in the
Analyst QS 1.1 software (MDS SCIEX) and then used to
search against the SwissProt database in the entries of
Rattus or Chordata on a local Mascot server with the
following parameters: one missed cleavage; peptide toler-
ance, 0.2 Da; MS/MS tolerance, 0.2 Da; cysteine carbam-
idomethylation as fixed modification; carbamidomethyl
1216 LIU ET AL. J Am Soc Mass Spectrom 2009, 20, 1214–1223(N-term), carbamidomethyl (K), and methionine oxida-
tion as variable modifications.
In the sequence query mode, the N-terminal se-
quence information was combined with the MS/MS
data to search against the SwissProt database. In this
type of search, the mass list in raw MS/MS data was
uploaded in an ions qualifier, whereas the N-terminal
sequence information derived from a1 enhancement
was included in a sequence qualifier.
Results and Discussion
Enhancement of a1 Ions in N-carbamidomethyl
Derivatives of Model Peptides
Iodoacetamide, a widely used derivatization reagent in
proteomics for the alkylation of sulfhydride groups in
peptides and proteins, was used to react with the
N-terminal amino groups in peptides, thus leading to
formation of carbamidomethyl derivatives at peptide
N-termini. These carbamidomethyl derivatives were
commonly viewed as undesired by-products formed
during iodoacetamide derivatization of reduced cys-
teine residues in peptides [21, 22]. During the mass
spectrometric analysis of these derivatives, however, an
enhancement of the modified a1 ions was observed in
the product ion spectra.
Figure 1 exhibits an LC-MS/MS analysis of a model
peptide PDAATAAPLR after the reaction with iodoac-
etamide at 37 °C for 60 min. The chromatographic peak
eluted at 30.25 min showed the doubly charged molec-
ular ion of the underivatized peptide at m/z 491.8
(Figure 1a). The other peak eluted at 31.15 min with an
Figure 1. LC-MS/MS analysis of PDAATAAP
well as product ion spectra for (b) m/z 491.8 and (c)m/z value of 520.3 represents the doubly charged mo-
lecular ion of its carbamidomethyl derivative. A differ-
ence of 57 Da in the molecule weight was observed
between the above two compounds. Figure 1b and c
show the product ion spectra recorded following low-
energy collision fragmentation of the [M  2H]2 ions
of the peptide PDAATAAPLR and its carbamidomethyl
derivative, respectively. In the product ion spectrum of
underivatized peptide PDAATAAPLR, several a series
ions such as a1 and a2 were detected in the lowmass range
of the spectrum, along with the b series ions (except for b1
ion). Interpretation of the product ion spectrum corre-
sponding to the peak at 31.15 min confirmed that the
compound represented the N-carbamidomethyl deriva-
tive of PDAATAAPLR because the m/z values of the
detected y series ions were the same as those observed
for the underivatized PDAATAAPLR, while the mass
values of both a and b series ions were 57 Da higher
than those detected in the underivatized peptide. No-
ticeably, an enhancement of the modified a1 ion at m/z
127 was observed in the product ion spectrum, whereas
the patterns of fragmentation pathway and relative
intensity of other series ions were almost the same as
those observed in the product ion spectrum of the
underivatized peptide. The analytical results from the
specific enhancement of a1 ion with N-terminal mod-
ification by iodoacetamide readily provided informa-
tion of N-terminal amino acid residue of the peptide.
Applicability of the method developed with the en-
hancement property of the a1 ion of the N-carbamidomethyl
derivative of PDAATAAPLR was extended to other pep-
tides. Figure 2 shows the total ion chromatograph (TIC)
ter the reaction with iodoacetamide: (a) TIC asLR af
m/z 520.3.
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MS/MS analysis of carbamidomethyl derivatives of
octreotide that is a cyclic octapeptide with a disulfide
bond linked between the two cysteines and with a
monoisotopic molecular weight of 1018.4. The detailed
structures of octreotide and its reduced form were
presented in Figure S1 in supplementary materials,
which can be found in the electronic version of this
article. The octreotide derivatives were formed from the
incubation of octreotide in bicarbonate buffer contain-
ing iodoacetamide at 37 °C for 60 min. The XIC chro-
matograph extracted at m/z 510.2 represented the peak
of the doubly charged molecular ion of octreotide
(Figure 2b). The product ion spectrum (Figure 3a) of the
underivatized octreotide was very simple under low
collision energy due to its cyclic structure. The fragment
ion at m/z 120 was the immonium ion of the N-terminal
Phe residue, whereas the ion at m/z 106 was the y1 ion
of octreotide. The XIC chromatograph in Figure 2c,
extracted at m/z 538.7, showed two peaks at 11.43 and
12.02 min, respectively, indicating that two different
forms of mono-carbamidomethyl derivatives of oct-
reotide might exist in the reaction mixture. The product
ion spectrum (Figure 3b) of the peak eluted at 11.43 min
with m/z 538.7 showed a similar fragmentation patterns
as that of the underivatized octreotide (Figure 3a),
indicating that the carbamidomethyl moiety was not
added on the amino group of the N-terminal Phe
residue. The other residue with possibility to react with
iodoacetamide in this peptide was Lys, which had an 
amino group in the side chain. Similar to the underi-
vatized peptide, a1 ion at m/z 120 was observed as base
peak. In the product ion spectrum of the peak eluted at
12.02 min with m/z 538.7 (Figure 3c), on the other hand,
the intensive a1 ion peak of carbamidomethyl derivative
Figure 2. LC-MS/MS analysis of octreotide afte
XIC for (b) m/z 510.2, (c) m/z 538.7, and (d) m/z 567.2was detected at m/z 177, which was 57 Da higher than
the ion at m/z 120. The observation of this ion allowed
the confirmation of the N-terminal Phe residue.
Besides the ion peaks at m/z 510.2 and 538.7, a minor
doubly charged ion peak at m/z 567.2 was detected from
the analysis of the reaction mixture, indicating that the
derivatized octreotide might have two carbamidom-
ethyl moieties. The XIC chromatograph (Figure 2d) at
m/z 567.2 shows a peak at 11.61 min, which had the
same elution time as that of the underivatized oct-
reotide (Figure 2b). The product ion spectrum (Figure
3d) of m/z 567.2 was very similar to that of the peak
eluted at 12.02 min with m/z 538.2 (Figure 3c). Again,
the detection of the intensive ion peak at m/z 177
indicated that the amino group of N-terminal Phe was
modified by iodoacetamide, while the other carbam-
idomethyl moiety might be introduced at another site,
probably in the  amino group of Lys residue.
In addition to the cyclic octreotide, the developed
method was also applied for the investigation of the
reduced octreotide. The enhancement of the a1 ion in
product ion spectra was again achieved from the carb-
amidomethyl derivatization with iodoacetamide (Fig-
ure 4). Three different reaction products of carbam-
idomethyl derivatives were detected in the reaction
mixture of the reduced octreotide. Results of the
MS/MS analyses of the carbamidomethyl derivatives of
the reduced octreotide exhibited the series of b and y
ions, which provided the sequence information of the
peptides.
Figure 4a showed the product ion spectrum of one of
three carbamidomethyl derivatives, which had the m/z
value at 568.3. The MS/MS analysis and spectrum interpre-
tation allowed the identification of the S-carbamidomethyl
derivative resulted from the alkylation at sulfhydride
reaction with iodoacetamide: (a) TIC as well asr the
.
in.
1218 LIU ET AL. J Am Soc Mass Spectrom 2009, 20, 1214–1223groups of the two Cys residues. The other two reaction
products with the same m/z value of 596.8 but different
elution time (Figure 4b) were also investigated. The prod-
uct ion spectrum of the minor peak eluted at 40.2 min
(Figure 4c) indicated that this compound was a carbam-
idomethyl derivative with two S-carbamidomethylated
cysteines and one N-carbamidomethylated lysine. The
very similar spectra in the low end (m/z 200) in Figure
4a and c suggested that the N-terminal Phe residues in
the two compounds were underivatized. However, in
the product ion spectrum of the major peak of m/z 596.8
eluted at 49.6 min, the a1 ion was greatly enhanced after
the N-terminal derivatization with iodoacetamide. The
observation of the derivatized a1 ion at m/z 177 (Figure 4d)
suggested that this compound might be an N-terminally
carbamidomethylated derivative with additional two S-
carbamidomethylated cysteines. Noticeably, c1 ions at m/z
165 (underivatized) and m/z 222 (derivatized) were ob-
served with high abundance, confirming the N-terminal
phenylalanine residue.
The formation of a1 ions as immonium species has
been considered to occur via either direct dissociation of
b2 to a1 or indirect fragmentation of a2 to a1 [10]. It was
found in this study that a1 ion of a peptide could be
Figure 3. LC-MS/MS analysis of octreotide a
spectrum for (a) m/z 510.2 eluted at 11.61 min, (
at 12.02 min, and (d) m/z 567.2 eluted at 11.61 mremarkably enhanced and stabilized when a carbam-idomethyl moiety is introduced at the amine of the
N-terminus of peptide, which could be easily rational-
ized as the proton stabilizing effect of amino group in
the carbamidomethyl moiety. Under the mild reaction
conditions, N-carbamidomethylation by iodoacetamide
was inclined to take place at  amino groups in the
N-terminal residues. Even though the epsilon amino
group of the lysine residue and the sulfhydride group
of cysteine might be other liable moieties, the possible
modified immonium ions with m/z values of 158.1
(modified immonuim ion of lysine) and 133.1 (modified
immonuim ion of cysteine) were not detected under the
low-energy collision condition, which allowed the low
end of the product ion spectrum unchanged after carb-
amidomethyl derivatization at internal residues such as
lysine and cysteine. Thus, the specificity of enhance-
ment of a1 ion by carbamidomethyl derivatization at 
amino groups in the N-terminal residues was high and
useful in mass spectrometric sequencing of peptides.
The carbamidomethyl derivatization with iodoacet-
amide appeared to be incomplete under the mild con-
ditions used in the present study. The incompleteness
of the reaction allowed the direct comparison of the
MS/MS spectra of the modified peptides with those of
the reaction with iodoacetamide: product ion
z 538.7 eluted at 11.43 min, (c) m/z 538.7 elutedfter
b) m/the unmodified peptides, through which the enhanced
6.8.
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amino acid residue could be determined. Specifically,
when the peptides were derived from tryptic digestion,
the comparison of the spectra was straightforward
because the fragment ions at high-end of the MS/MS
spectra, most of which belonged to y series ions, re-
mained unchanged after N-terminal carbamidomethy-
lation. It should be noted that the a1 ion in the MS/MS
spectrum of a modified peptide could not be assigned
without the comparison with that of the intact peptide
because other immonium ions from internal residues
were usually intermixed with the enhanced a1 ion in the
low end of MS/MS spectrum.
Applications of Enhancement of a1 Ions by
N-carbamidomethyl Derivatization for
Protein Identification
Although the reduction of disulfides by DTT followed
by alkylating the sulfhydryl groups with iodoacetamide
and the subsequent enzymatic digestion followed by
LC-MS/MS analysis have been widely applied for
protein identification [23–27], observation of the en-
hanced a1 ions from N-terminal carbamidomethylation
Figure 4. LC-MS/MS analysis of the reduced
product ion spectrum for (a) m/z 568.3 eluted at
596.8 eluted at 49.68 min and XIC for (b) m/z 59and its application for peptide sequencing and proteinidentification have not been reported. Because the ex-
cess iodoacetamide could readily react with the  amino
groups of the N-terminal residues, the carbamidom-
ethylation was observed as previously reported [22]
and should be included in the combination of variable
modifications during the database searching process.
The method was then applied to the analysis of the
tryptic digest of myoglobin. The tryptic digest of this
model protein was prepared in a manner that was very
similar with the commonly used protocol in which
iodoacetamide was used to alkylate sulfhydryl groups
of Cys after reduction with DTT. The excess iodoacet-
amide was usually left in the digestion mixture. More-
over, the digestion conditions (37 °C, pH 7.5–8.0 and
16–20 h) favor the reaction of iodoacetamide with
amino groups in the peptides.
Table 1 summarized results from the LC-MS/MS
analysis of tryptic digest of myoglobin. A total of 17
unique sequences in myoglobin were identified with
sequence coverage of 96.7%. For most of the sequences
identified, signals of both underivatized peptides and
their carbamidomethyl derivatives were detected. Inter-
pretation of the MS/MS spectra of the carbamidom-
ethyl derivatives indicated that most carbamidomethy-
reotide after the reaction with iodoacetamide:
0 min, (c) m/z 596.8 eluted at 40.10 min, (d) m/zoct
46.7lation took place at N-termini of the peptides, whereas
grou
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residues were only found in two sequences, namely
peptide 32–42 and peptide 64–77 listed in Table 1.
Figure 5 showed the product ion spectra of an intact
tryptic peptide (ALELFR) from the doubly charged ion
at m/z 374.7 (Figure 5a) and the corresponding carbam-
idomethyl derivative from the doubly charged ion at
m/z 403.2 (Figure 5b). As expected, a modified a1 ion at
m/z 101.1 was observed with high abundance in the
product ion spectrum of the doubly charged carbamidom-
ethyl derivative at m/z 403.2, confirming that the N-
terminal residue in this peptide was Ala. The enhance-
ments of a1 ions were also found in the MS/MS spectra of
other N-terminally carbamidomethyl derivatives, allow-
ing the rapid determination of the N-terminal residues of
these tryptic peptides with high specificity. It should be
pointed out that at high-temperature (e.g., 60 °C) the
Table 1. Summary of LC-MS/MS analysis of tryptic digest of m
Position Peptide sequence
1–16 GLSDGEWQQVLNVWGK
17–31 VEADIAGHGQEVLIR 8
32–42 LFTGHPETLEK 6
43–45 FDK
46–47 FK
48–50 HLK
51–56 TEAEMaK
57–63 ASEDLKK
64–77 HGTVVLTALGGILK
80–96 GHHEAELKPLAQSHATK
99–102 IPIK
103–118 YLEFISDAIIHVLHSK 9
120–133 HPGDFGADAQGAMTK 7
134–139 ALELFR 7
140–145 NDIAAK 6
146–147 YK
148–153 ELGFQG
aOxidized methionine (M).
bBoth the  amino group of N-terminal residue and the epsilon amino
cNot detected.
Figure 5. LC-MS/MS analysis of a peptide (AL
tive from the tryptic digest of myoglobin: product ioreaction would not only produce N-terminal carbamidom-
ethyl derivatives, but also generate several other types of
derivatives resulted from carbamidomethylation at Arg,
His, or from O-carbamidomethylation at C-terminal car-
boxylic group [21]. Nielsen et al. also reported the obser-
vation of alkylation of lysine with 2 mol iodoacetamide
[28]. These unwanted derivatives made the MS/MS spec-
tra interpretation more difficult. The problem, however,
was not detected under the mild reaction conditions used
in this study. When the concentration of iodoacetamide
was 5 mM, the N-terminal derivatization reaction ap-
peared to be very slow. On the other hand, no difference
in the reactions was observed when the concentration of
iodoacetamide was 55 mM and 100 mM. Therefore, the
concentration of iodoacetamide at 55 mM, which has been
used routinely in most proteomics labs, was used in this
study.
obin
m/z (Monoisotopic) and charges
Unmodified Carbamidomethyl derivatives
05.96(3) 936.95(2)
2(2), 536.28(3) 832.40(2), 555.29(3)
2(2), 424.56(3) 664.82(2)b, 443.57(3)b
09.20(1) 466.21(1)
94.18(1) 351.19(1)
97.24(1) 454.26(1)
24.28(1) 781.32(1)
95.71(2) 424.22(2)
89.90(2) 718.40(2)b
18.64, 464.23 637.64, 478.50
70.31(1) 527.35(1)
8(2), 629.01(3) 971.50(2), 648.00(3)
1(2), 501.54(3) 780.31(2), 520.56(3)
2(1), 374.72(2) 805.43(1), 403.23(2)
2(1), 316.17(2) NDc
10.17(1) 367.18(1)
50.29(1) NDc
p of Lysine (K) were carbamidomethylated.
R) and its N-terminal carbamidomethyl deriva-yogl
6
03.9
36.3
4
2
3
7
3
6
6
4
42.9
51.8
48.4
31.3
3
6ELF
n spectrum for (a) m/z 374.7 and (b) m/z 403.2.
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tion in protein identification by database searches after
the LC-MS/MS analysis of tryptic digest of a whole
protein extract from rat heart was subsequently per-
formed. After recorded and converted into the corre-
sponding MGF files, the mass spectrometric data were
loaded into an in-house Mascot server to search in the
Rattus database with or without variable modifications
of carbamidomethyl (N-term) and carbamidomethyl
(K). The detailed results for the identification of the first
20 hits are listed in Table S1 of the supplementary
materials. Most peptides in the identified proteins were
found to undergo N-terminal carbamidomethylation to
some extent. An example for the identification of car-
diac actin was demonstrated with the result shown in
Figure S2 in supplementary materials. A Total of 17
unique peptides were identified, 10 of which were
N-terminally carbamidomethylated. Enhancements
of a1 ions were found in the MS/MS spectra of the
N-terminal derivatives, allowing determination of N-
terminal residues and thus confirming the results from
database search.
It should be pointed out that the N-terminal carbam-
idomethyl derivatization was seldom found in mass spec-
trometric analysis of samples from in-gel digests, since the
iodoacetamidewas oftenwashed away before the enzyme
was added. However, the N-terminal carbamidomethyla-
tion readily occur during the analysis of the samples
prepared by in-solution digestion. The excess iodoacet-
amide from the process of sample preparation would
readily react with the N-terminal  amino acid groups,
and thus the N-terminal carbamidomethylation should
be considered as a variable modification during the
database searching process. Even though the inclu-
sion of N-terminal alkylation contributed insignifi-
cant gains in peptide identifications [29], the devel-
oped method could be applied to validate the
identified peptide sequences obtained from ordinary
MS/MS ion database search.
Figure 6. LC-MS/MS analysis of a peptide (V
ethyl derivative from the tryptic digest of rat hea
(b) m/z 614.9.Added Specificity of Protein Identification through
the Detection of N-Terminal Tags
The term “sequence tag” was first proposed by Mann
and Wilm at EMBL [30], which was used as the combi-
nation of a few residues of sequence data for protein
identification through database search. Sequence tag
search algorithm has since been well developed and used
as a powerful tool for protein identification though data-
base search [31–33]. As shown in the above examples, the
N-terminal information in peptides could be obtained
from the detection of the enhanced a1 ions by N-terminal
carbamidomethyl derivatization. This information of N-
terminal residue in certain peptides could be viewed as a
special sequence tag, which would increase the specificity
of protein identification during database searching by
narrowing down the candidate list.
As an example, a peptide derived from ATPase
was identified when the information of its a1 ion was
included in the database search. Figure 6a and b
showed the two product ion spectra from the ions at
m/z 586.4 and m/z 614.9, respectively. While molecu-
lar weight of the two peptides showed a difference of
57 Da, the same y series ions were observed in the
two MS/MS spectra in the high mass end, which
suggested that the fragmentations were produced
from the same sequence except that one of the
peptides was N-terminally carbamidomethylated.
The mass list of product ion spectrum of the ion at
m/z 586.4 (Figure 6a) was generated by the script built
in the Analyst QS, and searched against the SwissProt
database in the sequence query mode. A score of 15
for a peptide (VVDALGNAIDGK) derived from ATP
synthase was obtained, whereas the individual ions
scores indicating identity or extensive homology (P 
0.05) were above 19 (Figure S2 in supplementary
materials). So the result was considered as negative,
or not confident.
LGNAIDGK) and its N-terminal carbamidom-
sues: product ion spectrum for (a) m/z 586.3 andVDA
rt tis
1222 LIU ET AL. J Am Soc Mass Spectrom 2009, 20, 1214–1223Fortunately, in Figure 6b, a great enhancement of
the ion at m/z 129 was observed in the product ion
spectrum of the signal at m/z 614.9, indicating that the
N-terminal amino acid was valine. Therefore, this
N-terminal tag was combined with the above mass
list to re-search against the SwissProt database using
the same searching parameters as above. The result-
ant score for the peptide (VVDALGNAIDGK) was 15,
which was the same as that obtained without inclu-
sion of the information of the N-terminal amino acid.
However, in this case, because the individual ions
score indicating the identity or extensive homology
(P  0.05) was lowered to 10 due to the inclusion of
N-terminal tag, the result turned out to be positive,
indicating that peptide (VVDALGNAIDGK) was confi-
dently identified (Figure S3 in supplementary materials).
The sequence query search algorithm was often
initiated with the determination of certain sequence
tag, which was usually obtained by de novo sequenc-
ing. Therefore, the a1 ion assignment by N-terminal
carbamidomethylation was likely suitable for the
interpretation of MS/MS data by de novo sequencing
or de novo sequencing-based search algorithms (e.g.,
sequence query in MASCOT).
Conclusions
A simple and effective method to enhance a1 ions in
tandem mass spectrometry analysis with low collision
energy was developed by using carbamidomethylation at
 amino moieties of N-terminal amino acids in peptides.
The N-terminal carbamidomethylation by iodoacetamide
was demonstrated to be compatible with the sample
preparation protocol in proteomics analysis. The method
was effective and specific due to the proton stabilizing
effect of amino group in the carbamidomethylmoiety. The
developed method was proven to be useful for de novo
peptide sequencing with mass spectrometric analysis. The
method could also be considered as a major artificial
modification when the peptide digests were prepared in
an environment with excess iodoacetamide for a long
time, similar to the widely used protocol for in-solution
digestion. Moreover, the added specificity of protein
identification could be achieved when the informa-
tion of N-terminal residues was included in the
database searches. The method may be extended to
the application for quantitative proteomics when the
stable isotope labeled iodoacetamide is available for
the sample preparation.
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